News

Article

Envision Summit 2025: Importance of comanagement in glaucoma treatment

Key Takeaways

  • Co-managing glaucoma involves selecting therapeutics based on mechanism, efficacy, and tolerability, emphasizing strategic interventional therapies and surgical decisions.
  • Collaboration between optometrists and ophthalmologists is essential for effective glaucoma patient care.
SHOW MORE

At the Envision Summit 2025 in San Juan, Puerto Rico, Jessica Steen, OD, FAAO talked with glaucoma surgeons on the importance of comanaging patients throughout their lifetime.

Jessica Steen, OD, FAAO, Nova Southeastern University College of Optometry, discussed the importance of co-managing glaucoma patients throughout their lifetime – emphasizing the selection of therapeutics based on mechanism of action, efficacy, and tolerability, and the strategic use of interventional therapies and surgical decision-making. Steen highlighted the necessity of collaboration between optometrists and ophthalmologists for effective patient care. She also expressed excitement about new therapeutics in clinical trials, including those for neurodegeneration and neuroprotection, which extend beyond intraocular pressure (IOP) reduction.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.